ACLU Files for Second Supreme Court Review of Myriad's Gene Patents | GenomeWeb

NEW YORK (GenomeWeb News) – The American Civil Liberties Union and the Public Patent Foundation have asked the US Supreme Court to take up the question of gene patenting for a second time by looking again at the patentability of Myriad Genetics' claims on genes that predict risk of breast and ovarian cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.